Invesaro

Stocks Comparison

Teladoc Health vs Oncology Institute: revenue, profit, margins and growth compared

Teladoc Health brought in $2.5B of revenue in fiscal 2025, Oncology Institute $502.7M in fiscal 2025. Revenue changed by -1.5% at Teladoc Health and +27.8% at Oncology Institute on the year before, so Oncology Institute grew faster. Teladoc Health kept -7.9% of its revenue as net profit, Oncology Institute -12.1%. Free cash flow was $285.5M at Teladoc Health and -$27.8M at Oncology Institute.

Side by side, latest fiscal year

TDOCTOI
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.5B$502.7M
Revenue growth-1.5%+27.8%
Net income-$200.3M-$60.6M
Net margin-7.9%-12.1%
Free cash flow$285.5M-$27.8M
Free cash flow margin11.3%-5.5%
Earnings per share (diluted)-$1.14-$0.54
Cash$781.1M$33.6M
Debtn/a$77.4M
Price to earningsn/an/a
Market value$1.1B$522.8M
Dividend yieldn/an/a
Rank by revenue in sector#102 of 742 · Health care#204 of 742 · Health care

Over the years

Revenue
TDOC FY2018: $417.9MTDOC FY2019: $553.3MTDOC FY2020: $1.1BTDOC FY2021: $2BTDOC FY2022: $2.4BTDOC FY2023: $2.6BTDOC FY2024: $2.6BTDOC FY2025: $2.5BTOI FY2020: $187.5MTOI FY2021: $203MTOI FY2022: $252.5MTOI FY2023: $324.2MTOI FY2024: $393.4MTOI FY2025: $502.7MFY18FY19FY20FY21FY22FY23FY24FY25
TDOC $2.5BTOI $502.7M
Net income
TDOC FY2018: -$97.1MTDOC FY2019: -$98.9MTDOC FY2020: -$485.1MTDOC FY2021: -$428.8MTDOC FY2022: -$13.7BTDOC FY2023: -$220.4MTDOC FY2024: -$1BTDOC FY2025: -$200.3MTOI FY2020: -$14.3MTOI FY2021: -$10.9MTOI FY2022: $152KTOI FY2023: -$83.1MTOI FY2024: -$64.7MTOI FY2025: -$60.6MFY18FY19FY20FY21FY22FY23FY24FY25
TDOC -$200.3MTOI -$60.6M
Net margin
TDOC FY2018: -23.2%TDOC FY2019: -17.9%TDOC FY2020: -44.3%TDOC FY2021: -21.1%TDOC FY2022: -567.5%TDOC FY2023: -8.5%TDOC FY2024: -39.0%TDOC FY2025: -7.9%TOI FY2020: -7.6%TOI FY2021: -5.4%TOI FY2022: 0.1%TOI FY2023: -25.6%TOI FY2024: -16.4%TOI FY2025: -12.1%FY18FY19FY20FY21FY22FY23FY24FY25
TDOC -7.9%TOI -12.1%
Revenue growth
TDOC FY2019: +32.4%TDOC FY2020: +97.7%TDOC FY2021: +85.8%TDOC FY2022: +18.4%TDOC FY2023: +8.1%TDOC FY2024: -1.3%TDOC FY2025: -1.5%TOI FY2021: +8.3%TOI FY2022: +24.4%TOI FY2023: +28.4%TOI FY2024: +21.3%TOI FY2025: +27.8%FY19FY20FY21FY22FY23FY24FY25
TDOC -1.5%TOI +27.8%
Free cash flow
TDOC FY2018: -$8.9MTDOC FY2019: $26.4MTDOC FY2020: -$57.5MTDOC FY2021: $185.5MTDOC FY2022: $172.8MTDOC FY2023: $338.6MTDOC FY2024: $282.9MTDOC FY2025: $285.5MTOI FY2020: -$686KTOI FY2021: -$35.5MTOI FY2022: -$67.3MTOI FY2023: -$40.9MTOI FY2024: -$30.3MTOI FY2025: -$27.8MFY18FY19FY20FY21FY22FY23FY24FY25
TDOC $285.5MTOI -$27.8M

Fiscal years as each company reports them; the two may end in different months.

Questions about Teladoc Health and Oncology Institute

Which is bigger by revenue, Teladoc Health or Oncology Institute?

Teladoc Health is bigger by revenue: $2.5B in fiscal 2025, against $502.7M for Oncology Institute in fiscal 2025.

Which keeps more of its revenue as profit, Teladoc Health or Oncology Institute?

Teladoc Health had a net margin of -7.9% in fiscal 2025; Oncology Institute had -12.1% in fiscal 2025.

Which grew revenue faster, Teladoc Health or Oncology Institute?

In their latest fiscal years revenue changed by -1.5% at Teladoc Health and +27.8% at Oncology Institute.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies